The Hidden Risks of America's Most Popular Painkiller
January 26, 2026
20,461
456
27
2.36%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
The Wall Street Journal Episodes Around January 26, 2026
See what was published immediately before and after this episode.
1:21Now PlayingThe Hidden Risks of America's Most Popular Painkiller
YouTube Description
as posted by the channelGabapentin has soared in popularity as an alternative to opioids, but patients are finding it can cause harm.
Approved by the Food and Drug Administration decades ago for seizures and nerve pain from shingles, gabapentin is now the seventh-most widely prescribed drug in the U.S., according to the Iqvia Institute for Human Data Science.
Gabapentin helps many patients, and most tolerate it well, said Kirk Evoy, a clinical associate professor of pharmacotherapy and translational sciences at the University of Texas at Austin who studies gabapentin misuse. Still, he said, “we shouldn’t be thinking of gabapentin as this safe drug we can just try for anything and see if it helps.”
#Drugs #Healthcare #WSJ
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.